<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="topic" /><meta name="keywords" content="Diabetic: neuropathy; Duloxetine: diabetic neuropathy; Antidepressants: tricyclic: diabetic neuropathy; Amitriptyline: diabetic neuropathy; Nortriptyline: diabetic neuropathy; Pregabalin: diabetic neuropathy; Analgesics: opioid: diabetic neuropathy; Gabapentin: diabetic neuropathy; Carbamazepine: diabetic neuropathy; Capsaicin: diabetic neuropathy; Tetracycline: diabetic neuropathy; Codeine: diabetic neuropathy; Metoclopramide: diabetic neuropathy; Domperidone: diabetic neuropathy; Fludrocortisone: diabetic neuropathy; Flurbiprofen: diabetic neuropathy; Midodrine; Antimuscarinics: diabetic neuropathy; Ephedrine: diabetic neuropathy" /><meta name="IX" content="Diabetic: neuropathy; Duloxetine: diabetic neuropathy; Antidepressants: tricyclic: diabetic neuropathy; Amitriptyline: diabetic neuropathy; Nortriptyline: diabetic neuropathy; Pregabalin: diabetic neuropathy; Analgesics: opioid: diabetic neuropathy; Gabapentin: diabetic neuropathy; Carbamazepine: diabetic neuropathy; Capsaicin: diabetic neuropathy; Tetracycline: diabetic neuropathy; Codeine: diabetic neuropathy; Metoclopramide: diabetic neuropathy; Domperidone: diabetic neuropathy; Fludrocortisone: diabetic neuropathy; Flurbiprofen: diabetic neuropathy; Midodrine; Antimuscarinics: diabetic neuropathy; Ephedrine: diabetic neuropathy" /><title>Diabetic neuropathy: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="31494.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="31494.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=31494.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2073.htm">6 Endocrine system</a> &gt; <a href="4080.htm">6.1 Drugs used in diabetes</a> &gt; <a href="4201.htm">6.1.5 Treatment of diabetic nephropathy and neuropathy</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="31495.htm" title="Previous: Diabetic nephropathy">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="4202.htm" title="Next: 6.1.6 Diagnostic and monitoring devices for diabetes mellitus">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_31494">Diabetic neuropathy</h1><?highlighter on?><div id="pC" class="jN"><p>Optimal
diabetic control is beneficial for the management of <i>painful
neuropathy</i> in patients with type 1 diabetes (see also <a title="BNF:sub-section: Neuropathic pain" href="3548.htm#_3548">section 4.7.3</a>). <a title="BNF:monograph: PARACETAMOL" href="3469.htm#_3469"><b>Paracetamol</b></a> or a non-steroidal anti-inflammatory
drug such as <a title="BNF:monograph: IBUPROFEN" href="5192.htm#_5192"><b>ibuprofen</b></a> may relieve <i>mild to moderate
pain</i>.</p><p><span><a title="BNF:monograph: DULOXETINE" href="129245.htm#_129245"><b>Duloxetine</b></a></span>  is effective for the treatment of painful
diabetic neuropathy; <span><a title="BNF:monograph: AMITRIPTYLINE HYDROCHLORIDE" href="3297.htm#_3297"><b>amitriptyline</b></a></span> [unlicensed use] can be
used if duloxetine is ineffective or unsuitable. <a title="BNF:monograph: NORTRIPTYLINE" href="3322.htm#_3322"><span><b>Nortriptyline</b></span></a> [unlicensed] may be better tolerated
than amitriptyline. If treatment with amitriptyline or duloxetine
is inadequate, treatment with <a title="BNF:monograph: PREGABALIN" href="129077.htm#_129077"><span><b>pregabalin</b></span></a> should be tried. Combination therapy
of duloxetine or amitriptyline with pregabalin can be used if monotherapy
at the maximum tolerated dose does not control symptoms.</p><p>Neuropathic pain may respond to opioid analgesics. There is
evidence of efficacy for <a title="BNF:monograph: TRAMADOL HYDROCHLORIDE" href="17872.htm#_17872"><b>tramadol</b></a>, <a title="BNF:monograph: MORPHINE SALTS" href="3492.htm#_3492"><b>morphine</b></a>, and <a title="BNF:monograph: OXYCODONE HYDROCHLORIDE" href="85406.htm#_85406"><b>oxycodone</b></a>; however, treatment with
morphine or oxycodone should be initiated only under specialist supervision.
Tramadol can be prescribed while the patient is waiting for assessment
by a specialist if other treatments have been unsuccessful.</p><p><a title="BNF:monograph: GABAPENTIN" href="3614.htm#_3614"><b>Gabapentin</b></a> and <a title="BNF:monograph: CARBAMAZEPINE" href="3577.htm#_3577"><b>carbamazepine</b></a> are sometimes used for the treatment
of neuropathic pain. <a title="BNF:monograph-family: Capsaicin" href="5356.htm#_5356"><b>Capsaicin</b></a> cream 0.075% is licensed for painful diabetic neuropathy
and may have some effect, but it produces an intense burning sensation
during the initial treatment period.</p><p>In <i>autonomic neuropathy</i> diabetic diarrhoea
can often be managed by 2 or 3 doses of <a title="BNF:monograph: TETRACYCLINE" href="3805.htm#_3805"><b>tetracycline</b></a> 250 mg [unlicensed
use]. Otherwise <a title="BNF:monograph: CODEINE PHOSPHATE" href="2153.htm#_2153"><b>codeine</b></a> is the best drug, but other antidiarrhoeal
preparations can be tried. An antiemetic which promotes gastric transit,
such as <a title="BNF:monograph: METOCLOPRAMIDE HYDROCHLORIDE" href="3431.htm#_3431"><b>metoclopramide</b></a> or <a title="BNF:monograph: DOMPERIDONE" href="3429.htm#_3429"><b>domperidone</b></a>, is helpful for gastroparesis. In
rare cases when an antiemetic does not help, erythromycin (especially
when given intravenously) may be beneficial but this needs confirmation.</p><p>In <i>neuropathic postural hypotension</i> increased
salt intake and the use of the mineralocorticoid <a title="BNF:monograph: FLUDROCORTISONE ACETATE" href="4252.htm#_4252"><b>fludrocortisone</b></a> 100–400 micrograms
daily [unlicensed use] may help by increasing plasma
volume, but uncomfortable oedema is a common side-effect. Fludrocortisone
can also be combined with <a title="BNF:monograph: FLURBIPROFEN" href="5224.htm#_5224"><b>flurbiprofen</b></a> and <a title="BNF:monograph: EPHEDRINE HYDROCHLORIDE" href="2916.htm#_2916"><b>ephedrine hydrochloride</b></a> [both unlicensed]. <b>Midodrine</b> [unlicensed],
an alpha agonist, may also be useful in postural hypotension.</p><p><i>Gustatory sweating</i> can be treated with an antimuscarinic
such as <a title="BNF:monograph: PROPANTHELINE BROMIDE" href="2093.htm#_2093"><b>propantheline bromide</b></a>; side-effects are common.
For the management of hyperhidrosis, see <a title="section: Antiperspirants" href="6297.htm#_6297">section 13.12</a>.</p><p>In some patients with <i>neuropathic oedema</i>, ephedrine hydrochloride
[unlicensed use] 30–60 mg 3 times daily offers effective relief. </p><p>For the management of erectile dysfunction, see <a title="sub-section: Drugs for impotence" href="4674.htm#_4674">section 7.4.5</a>.</p></div><?highlighter on?><?highlighter off?><div id="pE">◄ <a accesskey="[" href="31495.htm">Previous: Diabetic nephropathy</a> | <a class="top" href="31494.htm#">Top</a> | <a accesskey="]" href="4202.htm">Next: 6.1.6 Diagnostic and monitoring devices for diabetes mellitus</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>